VISEN Pharmaceuticals
VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does VISEN Pharmaceuticals do?
VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for patients suffering from inflammatory and fibrotic diseases. Their lead drug candidate, VISN-101, is a novel small molecule inhibitor targeting a key pathway implicated in these conditions. The company aims to address significant unmet medical needs in areas like idiopathic pulmonary fibrosis (IPF) and other fibrotic disorders.
How much funding has VISEN Pharmaceuticals raised?
VISEN Pharmaceuticals has raised a total of $240M in funding. The most recent round on record is IPO.
Where is VISEN Pharmaceuticals headquartered?
VISEN Pharmaceuticals is headquartered in San Diego, United States.
When was VISEN Pharmaceuticals founded?
VISEN Pharmaceuticals was founded in 2017.
What industry does VISEN Pharmaceuticals operate in?
VISEN Pharmaceuticals operates in Biotech, Drug Discovery, Clinical Trials, Fibrotic Diseases, Inflammatory Diseases, MedTech.